Activity ID
12872Expires
October 7, 2024Format Type
Journal-basedCME Credit
1Fee
$30CME Provider: JAMA Neurology
Description of CME Course
This cohort study investigates the humoral response to 2 SARS-CoV-2 messenger RNA vaccines in patients with multiple sclerosis treated with fingolimod and ocrelizumab.
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
a. Discuss indications for emergency cesarean birth.
b. Describe risks associated with emergency cesarean birth.
c. Utilize at least one risk mitigation strategy for emergency cesarean birth.
Keywords
Demyelinating Disorders, Multiple Sclerosis, Neurology, Vaccination, Coronavirus (COVID-19)
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/jamaneurol.2021.3609
Practice Setting
Academic Medicine, Inpatient, Rural, Urban, VA/Military
